NIP-322

N/A

Report date: 2024/07/26 14:52:56
NMEFirst In Class

Base Information

Drug NameNIP-322
Drug Alias NameNIP-322
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSepiapterin reductase inhibitors
TargetsSepiapterin reductase
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNissan Chemical Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A